Evaluation of the Impact of Pneumococcal Conjugate Vaccine on Pediatric Community-Acquired Pneumonia Using an Emergency Database System | Zendy

Guilhem Noël | Zendy; Gilles Viudes | Zendy; R. Laporte | Zendy; Philippe Minodier | Zendy

Open Access

Evaluation of the Impact of Pneumococcal Conjugate Vaccine on Pediatric Community-Acquired Pneumonia Using an Emergency Database System

Author(s) -

Guilhem Noël,

Gilles Viudes,

R. Laporte,

Philippe Minodier

Publication year - 2016

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piw019

Subject(s) - medicine , pneumococcal conjugate vaccine , pneumonia , bronchiolitis , confidence interval , odds ratio , emergency department , community acquired pneumonia , logistic regression , pediatrics , pneumococcal pneumonia , streptococcus pneumoniae , respiratory system , genetics , psychiatry , bacteria , biology

A 13-valent pneumococcal conjugate vaccine (PCV13) seems to be associated with a reduction of community-acquired pneumonia (CAP) in children.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research